Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABT-751 in Taxane-Refractory Breast Cancer
NCT00063102Phase 2Completed
- Sponsor
- Abbott Laboratories
- Start
- Nov 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of abt-751 in breast cancer, sponsored by Abbott Laboratories. Started Nov 2002; status: completed.
02
Drugs
abt-751
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00063102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00063102.